Literature DB >> 18311573

Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.

Paul Roschger1, Nadja Fratzl-Zelman, Barbara M Misof, Francis H Glorieux, Klaus Klaushofer, Frank Rauch.   

Abstract

Osteogenesis imperfecta type I (OI-I) represents the mildest form of OI. The collagen I mutations underlying the disorder can be classified as quantitative mutations that lead to formation of a decreased amount of normal collagen or qualitative mutations where structurally aberrant collagen chains are generated. However, the phenotypic consequences of a particular mutation are not well understood. Transiliac bone biopsies from 19 young OI-I patients (age range 2.0-14.1 years) and 19 age-matched controls were used to assess bone histomorphometric parameters and bone mineralization density distribution, measured by quantitative backscattered electron imaging. Thirteen of the OI-I patients were affected by quantitative and six patients by qualitative mutations. Compared to age-matched controls, iliac bone samples in the OI group were smaller and had thinner cortices and less trabecular bone. Resorption parameters were similar between groups, whereas surface-based parameters of bone formation were considerably higher in OI patients than in controls with the exception of bone formation rate per osteoblast surface, which was reduced in OI. Backscattered electron imaging revealed a higher mean mineralization density (+7%, P < 0.001) in OI-I patients than in age-matched controls, which was accompanied by a reduced heterogeneity of mineralization (-13%, P < 0.001). However, the increase of mean degree of mineralization in OI did not exceed the average level of normal adult bone. No differences were found between the two mutation types. In summary, the tissue- and material-level abnormalities found in OI-I (low bone mass and increased mineral content of the matrix) seem to be independent of the collagen mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18311573     DOI: 10.1007/s00223-008-9113-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  38 in total

Review 1.  Methods for assessing bone quality: a review.

Authors:  Eve Donnelly
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

2.  Finite element analysis of bone strength in osteogenesis imperfecta.

Authors:  Peter Varga; Bettina M Willie; Chris Stephan; Kenneth M Kozloff; Philippe K Zysset
Journal:  Bone       Date:  2020-01-22       Impact factor: 4.398

Review 3.  Bone mineralization: from tissue to crystal in normal and pathological contexts.

Authors:  Y Bala; D Farlay; G Boivin
Journal:  Osteoporos Int       Date:  2012-12-11       Impact factor: 4.507

Review 4.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

5.  COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.

Authors:  Katarina Lindahl; Aileen M Barnes; Nadja Fratzl-Zelman; Michael P Whyte; Theresa E Hefferan; Elena Makareeva; Marina Brusel; Michael J Yaszemski; Carl-Johan Rubin; Andreas Kindmark; Paul Roschger; Klaus Klaushofer; William H McAlister; Steven Mumm; Sergey Leikin; Efrat Kessler; Adele L Boskey; Osten Ljunggren; Joan C Marini
Journal:  Hum Mutat       Date:  2011-04-07       Impact factor: 4.878

6.  Quantifying mineralization using bone mineral density distribution in the mandible.

Authors:  Alexis Donneys; Noah S Nelson; Sagar S Deshpande; Matthew J Boguslawski; Catherine N Tchanque-Fossuo; Aaron S Farberg; Steven R Buchman
Journal:  J Craniofac Surg       Date:  2012-09       Impact factor: 1.046

7.  Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta.

Authors:  Carolyne Albert; John Jameson; Peter Smith; Gerald Harris
Journal:  Bone       Date:  2014-06-11       Impact factor: 4.398

8.  The role of apoptosis in mineralizing murine versus avian micromass culture systems.

Authors:  Rani Roy; Valery Kudryashov; Itzhak Binderman; Adele L Boskey
Journal:  J Cell Biochem       Date:  2010-10-15       Impact factor: 4.429

Review 9.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

10.  Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I.

Authors:  Frank Rauch; Liljana Lalic; Peter Roughley; Francis H Glorieux
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.